Topic: MS

EAN HIGHLIGHTS 2023 – MONDAY, JULY 3 EDITION

July 3, 2023  

Novel approach to MS therapeutics: anti-CD40L

June 21, 2023  

CLINICAL CASES IN MS – A case of worsening mobility during the pandemic

June 13, 2023  

Re-evaluating the balance of efficacy and safety with disease-modifying therapies

June 8, 2023  

Selected highlights from CMSC 2023

June 6, 2023  

NfL – a guide to use in MS practice

May 31, 2023  

AAN update on anti-CD20 agents: long-term data

May 10, 2023  

Emerging role of CHI3L1 as MS biomarker

May 2, 2023  

sNfL a biomarker of future disease activity: APLIOS

April 12, 2023  

Is vitamin D supplementation justified?

April 5, 2023